<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.958" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">349</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M98.600 144.300 L103.680 144.300 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M236.240 155.300 L241.320 155.300 "/>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M62.360 369.300 L92.600 369.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,65.863,69.859,72.361,76.357,79.354,83.854,87.355,89.857,93.358,95.842,98.839,106.84,111.844,114.841,117.091,119.575,126.073,130.573,133.075,135.577,139.573,144.073,147.07,150.571,155.071,157.573,162.073,166.069,168.571,171.046,179.047,184.051,186.535,189.532,196.03,201.034,209.035,214.039,217.036,219.286,221.77,228.268,234.766,237.25,241.75,244.747,247.069,252.568,260.569,263.053,267.049,271.045,275.041,279.541,286.543,291.043,295.039" svgx:width="0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.33,0.39,0.5,0.28,0.5,0.44,0.28,0.25,0.89,0.56,0.25,0.33,0.72,0.56,0.89,0.56,0.33,0.25,0.25,0.72,0.72,0.25,0.5,0.33,0.25,0.61,0.89,0.25,0.44,0.44,0.44,0.5,0.78,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sclerosis (MS), Optico-spinal MS (OSMS), ON or TM accompa-</text>
   <text y="88.101" x="62.362,66.862,71.362,73.864,78.364,82.864,85.114,87.688,91.189,95.689,99.19,101.692,105.688,112.69,115.192,119.188,121.438,124.012,128.008,132.508,135.01,139.51,142.012,149.014,156.016,160.516,165.016,169.012,171.262,173.836,178.336,180.838,184.339,188.335,192.331,195.832,199.828,203.329,205.579,207.829,210.403,216.901,223.399,225.649,228.223,232.723,235.72,237.97,240.382,245.881,253.882,256.132,258.706,265.204,267.706,270.208,274.708,276.958,279.532,284.032,287.029,291.025,293.527,298.027" svgx:width="0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.39,0.5,0.39,0.28,0.44,0.78,0.28,0.44,0.25,0.55,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.55,0.72,0.72,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.89,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nying systemic autoimmune diseases, ON or TM with brain </text>
   <text y="99.099" x="62.362,64.864,68.86,72.361,74.863,79.363,83.863,87.364,89.614,93.115,97.615,102.115,106.615,110.611,114.112,116.614,119.116,123.616,128.116,130.366,136.864,144.865,151.363" svgx:width="0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.72,0.89,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lesions suggesting NMO.</text>
   <text y="110.097" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="110.097" x="96.463,102.961,107.461,111.457,113.707,114.562,119.062,123.562,128.062,132.562,135.559,139.555,144.055,146.305,147.16,151.156,155.656,160.156,162.406,163.261,166.258,170.758,173.755,176.257,180.757,183.007,183.862,188.362,190.864,195.364,199.36,201.61,202.465,205.462,209.962,214.462,216.712,221.212,228.709,231.706,233.956,234.811,237.808,241.804,248.806,252.802,255.304,259.3,261.55,262.405,266.401,270.901,275.401,277.651,278.506,281.008,285.508,288.01,291.007,293.509,298.009" svgx:width="0.72,0.5,0.44,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.28,0.33,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">One hundred and forty nine (81.9%) female and thirty </text>
   <text y="121.095" x="62.362,64.864,69.364,72.361,76.357,80.353,82.603,83.953,86.95,91.45,95.95,98.2,102.7,110.197,113.194,115.444,116.794,123.796,127.792,130.294,134.29,136.54,137.89,142.39,146.386,148.888,151.39,155.386,159.886,162.388,165.889,168.139,169.489,175.987,179.983,182.98,186.976,189.226,190.576,193.078,197.578,201.574,204.076,208.576,213.076,217.072,221.572,223.822,226.072,227.26,232.759,237.259,241.255,243.505,244.855,251.857,255.853,259.849,264.349,266.599,267.949,271.945,276.445,280.441,282.691,284.041,290.539,294.535,298.036" svgx:width="0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.78,0.44,0.28,0.44,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">three (18.1%) male patients were included. The mean age was </text>
   <text y="132.093" x="62.362,66.862,71.362,73.612,78.112,82.612,87.553,92.053,96.553,98.803,103.303,107.803,109.747,112.744,117.244,121.24,123.742,130.24,134.236,138.232,142.732,144.676,149.176,153.676,156.673,161.173,165.673,167.617,172.117,176.113,180.109,183.106,186.607,189.604,191.854,193.798,196.3,200.8,204.796,206.74,213.742,217.738,221.734,226.234,228.178,232.174,236.674,240.67,242.614,246.61,249.112,251.056,255.556,258.058,261.559,265.555,269.551,273.052,277.048,278.992,283.492,287.992,291.493,295.489,297.991" svgx:width="0.5,0.5,0.25,0.5,0.5,0.55,0.5,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.5,0.33,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.33,0.25,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.39,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">38.43±12.40 (between 13-75 years), the mean age at disease onset </text>
   <text y="143.091" x="62.362,68.86,72.856,76.357,78.355,82.855,87.355,89.605,94.105,98.605,103.681,108.181,112.681,114.931,119.431,123.931,125.929,128.926,133.426,137.422,139.924,146.422,150.418,154.414,158.914,160.912,165.412,169.912,172.909,177.409,181.909,184.906,187.156,188.992,194.491,198.991,202.987,204.985,208.981,213.481,217.477,219.475,223.471,225.973,227.971,232.471,234.973,238.474,242.47,246.466,249.967,253.963,255.961,260.461,264.961,268.462,272.458,274.96,276.958,283.456,287.452,290.953,292.951,298.027" svgx:width="0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.5,0.56,0.5,0.5,0.25,0.5,0.5,0.25,0.33,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.5,0.5,0.33,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.5,0.44,0.25,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.72,0.44,0.39,0.25,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was 31.29+12.40 (between 10-74). The age at disease onset was &lt; </text>
   <text y="154.089" x="62.362,66.862,71.362,73.612,74.602,79.102,83.098,87.094,90.091,93.592,95.842,96.832,99.334,103.834,106.084,107.074,111.574,116.074,120.574,122.824,123.814,128.314,132.31,134.812,137.314,141.31,145.81,148.312,151.813,154.063,155.053,158.05,162.55,167.05,169.3,173.8,181.297,184.294,186.544,187.534,194.032,198.532,201.034,203.536,207.532,209.782,210.772,213.274,215.776,218.026,219.016,225.514,229.51,233.011,235.261,236.251,241.327,243.577,244.567,249.067,253.567,255.817,256.807,261.307,265.303,269.299,272.296,275.797,278.047,279.037,282.034,287.533,291.529,294.031,298.027" svgx:width="0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.72,0.5,0.28,0.28,0.44,0.25,0.55,0.28,0.28,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.56,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.44,0.44,0.33,0.39,0.25,0.55,0.33,0.61,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">50 years in 166 patients (91.2%) while it was &gt; 50 years (Late </text>
   <text y="165.087" x="62.362,68.86,73.36,76.861,80.857,83.359,85.609,86.527,93.025,101.026,107.524,110.026,116.524,124.525,131.023,136.027,142.525,145.522,147.772,148.69,151.192,155.692,157.942,158.86,163.36,167.86,170.11,171.028,174.025,178.525,180.775,185.275,192.772,195.769,198.019,198.937,203.437,207.433,209.935,212.437,216.433,220.933,223.435,226.936,229.186,231.436,232.192,237.691,242.191,246.187,248.437,249.355,256.357,260.353,264.349,268.849,271.099,272.017,276.517,279.019,282.52,286.516,290.512,294.013,298.009" svgx:width="0.72,0.5,0.39,0.44,0.28,0.25,0.55,0.72,0.89,0.72,0.28,0.72,0.89,0.72,0.56,0.72,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.5,0.25,0.5,0.83,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Onset NMO/NMOSD) in 16 (8.8%) patients. The mean disease </text>
   <text y="176.085" x="62.362,66.862,71.362,74.359,78.355,80.857,83.359,87.859,92.359,94.609,95.968,102.466,106.462,109.963,112.213,113.572,118.072,122.572,124.822,129.322,133.822,138.763,143.263,147.763,150.013,154.513,159.013,161.263,162.622,169.624,174.124,178.624,181.126,185.626,189.127,191.377,193.627,194.824,199.693,206.191,210.187,214.687,217.189,221.689,223.939,225.298,228.295,232.795,237.295,240.292,242.542,243.901,246.898,251.398,255.898,263.395,266.392,268.642,270.001,274.501,278.497,280.999,283.501,287.497,291.997,294.499,298.0" svgx:width="0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.5,0.25,0.5,0.5,0.55,0.5,0.5,0.25,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.55,0.61,0.72,0.44,0.5,0.28,0.5,0.25,0.55,0.33,0.5,0.5,0.33,0.25,0.55,0.33,0.5,0.5,0.83,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">duration was 64.65±69.17 months. Twenty four (14%) patients </text>
   <text y="187.083" x="62.362,66.862,70.858,75.358,77.716,82.216,84.718,89.218,93.214,96.211,98.569,102.565,107.065,109.567,114.067,116.569,123.571,130.573,135.073,139.573,143.569,145.927,150.427,152.929,156.43,160.426,164.422,167.923,171.919,175.42,177.67,180.028,183.025,187.525,189.883,193.879,196.381,200.377,203.878,207.379,209.881,213.877,217.873,220.375,222.733,229.231,237.232,243.73,246.088,250.588,253.585,258.085,262.585,267.085,269.335,271.693,278.191,286.192,292.69,295.048,298.045" svgx:width="0.5,0.44,0.5,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.33,0.5,0.25,0.44,0.28,0.44,0.39,0.39,0.28,0.44,0.44,0.28,0.25,0.72,0.89,0.72,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.72,0.89,0.72,0.25,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">had other autoimmune diseases. In classical NMO group, NMO - </text>
   <text y="198.081" x="62.362,65.359,69.859,76.357,78.265,82.261,86.761,91.261,93.169,97.669,100.171,102.673,107.173,111.673,115.669,118.171,122.671,127.171,131.167,133.669,135.577,140.077,144.073,148.573,153.073,154.981,159.481,163.981,167.482,169.984,172.486,174.988,179.488,181.99,184.492,188.992,190.9,197.398,201.394,204.895,206.803,211.303,215.803,218.053,222.553,230.05,231.958,235.954,240.454,244.954,246.862,251.362,255.862,258.112,262.612,270.109,272.017,275.014,279.01,282.511,287.011,291.007,295.003" svgx:width="0.33,0.5,0.72,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.44,0.5,0.5,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IgG and oligoclonal band positivity was 62.5% and 20.4% respec-</text>
   <text y="209.079" x="62.362,64.864,67.366,71.866,75.862,78.364,82.279,84.529,87.22,93.718,98.218,102.718,107.218,111.214,113.716,115.966,116.902,121.402,124.399,128.899,133.399,136.396,140.392,143.893,147.394,149.896,154.396,158.896,161.146,162.082,164.584,169.084,173.584,177.58,182.08,184.33,185.266,191.764,195.76,199.261,201.511,202.447,205.948,208.45,212.95,217.45,219.952,222.949,225.451,229.447,233.443,237.943,240.445,242.947,247.447,249.697,250.633,255.133,257.635,262.135,266.635,270.631,273.628,275.878,276.814,279.316,283.816,286.066,287.002,289.504,294.004,298.0" svgx:width="0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25,0.72,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tively. Annual progression index was significantly higher in the </text>
   <text y="220.077" x="62.362,67.861,73.36,78.859,86.86,89.11,89.83,94.33,97.327,101.827,106.327,110.827,113.077,113.797,120.295,122.797,125.299,129.799,132.049,132.769,135.766,139.762,143.263,147.763,151.759,155.755,158.257,160.507,161.227,163.729,168.229,170.479,171.199,175.195,177.697,181.693,185.194,188.695,191.197,195.193,199.189,201.691,203.941,204.661,211.159,219.16,225.658,227.908,228.628,232.624,237.124,241.624,243.874,244.594,247.591,251.587,255.583,260.083,263.08,266.077,270.073,274.573,277.075,279.325,280.045,284.545,289.045,291.547,294.049,298.045" svgx:width="0.61,0.61,0.61,0.89,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.28,0.44,0.39,0.39,0.28,0.44,0.44,0.28,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LETM group with respect to classical NMO and recurrent optic </text>
   <text y="231.075" x="62.362,66.862,70.858,75.358,78.355,80.857,83.359,85.861,89.362,91.207,94.204,98.704,100.954,105.454,109.954,114.895,119.395,121.645,126.145,130.645,132.49,136.99,140.491,142.336,146.836,149.086,153.586,158.086,163.027,167.527,169.777,174.277,178.777,180.622,184.618,189.118,193.618,195.463,199.963,202.213,206.713,211.213,216.154,220.654,222.904,227.404,231.904,234.901,237.151,238.834,244.333,248.833,252.829,254.674,261.676,265.672,269.668,274.168,276.013,281.512,288.01,293.014,298.018" svgx:width="0.5,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.33,0.5,0.25,0.5,0.5,0.55,0.5,0.25,0.5,0.5,0.25,0.5,0.39,0.25,0.5,0.25,0.5,0.5,0.55,0.5,0.25,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.25,0.5,0.5,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.25,0.78,0.44,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">neuritis (0.70±1.73 vs 0.17±0.34 and 0.08±0.12). The mean EDSS </text>
   <text y="242.073" x="62.362,66.358,70.858,75.358,77.905,82.405,85.402,89.902,94.402,97.399,101.395,104.896,108.397,110.899,115.399,119.899,122.446,124.948,129.448,133.948,137.944,142.444,144.991,149.491,153.487,155.989,160.489,164.485,167.986,170.533,177.031,181.027,184.024,188.02,190.567,195.067,197.569,202.069,206.569,210.565,213.562,216.109,218.611,223.111,225.658,228.16,232.66,236.656,239.203,244.702,251.2,257.698,265.699,272.197,274.744,279.244,282.241,286.741,291.241,295.741,297.991" svgx:width="0.44,0.5,0.5,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.44,0.28,0.5,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.61,0.72,0.72,0.89,0.72,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and progression index values were higher in the LONMO group. </text>
   <text y="253.071" x="62.362,67.366,71.362,75.862,79.858,84.358,86.86,91.36,94.186,97.183,101.683,106.183,109.18,112.006,116.506,120.502,123.004,125.506,129.502,134.002,136.504,140.005,142.831,145.828,150.328,154.828,157.078,161.578,166.078,173.575,176.572,179.398,183.898,186.895,189.721,196.219,200.719,205.219,207.721,211.717,214.543,219.043,222.04,226.54,231.04,235.54,238.366,244.864,248.86,251.857,255.853,258.679,263.179,267.679,272.179,276.175,279.172,281.998,284.5,289.0,293.5,298.0" svgx:width="0.56,0.44,0.5,0.44,0.5,0.28,0.5,0.25,0.33,0.5,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.5,0.5,0.83,0.33,0.25,0.5,0.33,0.25,0.72,0.5,0.5,0.28,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Seventy four patients (41.34%) of whole group were under long </text>
   <text y="264.069" x="62.362,64.864,68.86,71.857,78.859,81.109,83.611,86.608,90.604,94.6,97.102,104.104,108.1,112.6,115.102" svgx:width="0.28,0.44,0.33,0.78,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">term treatment.</text>
   <text y="275.067" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="275.067" x="114.391,120.889,125.389,128.386,130.906,134.902,139.402,143.902,148.402,151.399,153.901,156.421,160.921,165.421,167.923,172.423,174.925,178.426,180.946,185.446,189.946,192.448,194.968,197.47,201.97,205.966,208.486,215.488,219.988,222.985,226.981,229.501,233.002,236.998,241.498,245.494,248.491,252.487,255.007,259.507,262.009,265.51,269.506,274.006,276.508,279.01,281.512,284.014,288.514,291.034,293.536,298.036" svgx:width="0.72,0.5,0.33,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.5,0.5,0.28,0.25,0.28,0.5,0.44,0.25,0.78,0.5,0.33,0.44,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.5,0.28,0.39,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our cohort points out the more severe disability in </text>
   <text y="286.065" x="62.362,68.86,76.861,83.359,85.861,92.359,100.36,106.858,111.862,118.36,120.61,121.636,126.136,130.132,132.634,135.136,139.132,143.632,146.134,149.635,151.885,152.911,157.411,160.408,164.404,167.905,171.901,176.401,178.903,181.405,185.905,190.405,192.655,193.681,200.179,202.681,205.183,209.683,211.933,212.959,215.461,218.458,222.454,226.954,230.455,234.955,238.951,241.948,245.449,249.445,251.695,252.721,259.723,264.223,268.219,270.721,273.223,275.725,278.227,281.728,283.978,285.004,289.0,293.5,298.0" svgx:width="0.72,0.89,0.72,0.28,0.72,0.89,0.72,0.56,0.72,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.5,0.44,0.33,0.39,0.44,0.25,0.55,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMO/NMOSD patients presenting with transverse myelitis and </text>
   <text y="297.063" x="62.362,64.864,68.86,71.362,75.358,77.608,82.108,86.608,90.109,94.105,96.607,98.857,102.358,106.858,111.358,115.858,118.855,123.355,127.855,132.355,135.856" svgx:width="0.28,0.44,0.28,0.44,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.39,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">late onset subgroups.</text>
   <text y="324.063" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P640</text>
   <text y="335.061" x="62.362,68.365,73.369,77.365,81.361,85.861,90.865,95.365,97.615,102.115,105.112,107.362,112.366,116.362,121.366,125.362,129.862,137.359,141.859,145.855,148.357,150.859,153.856,156.358,159.859,162.109,166.609,171.613,174.61,177.112,181.108,185.608,187.858,191.854,196.354,200.854,204.85,208.846,212.842,217.846,222.346,225.343,227.845,232.345,237.349,240.85,243.847,246.097,250.597" svgx:width="0.67,0.56,0.44,0.44,0.5,0.56,0.5,0.25,0.5,0.33,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5,0.25,0.44,0.5,0.5,0.44,0.44,0.44,0.56,0.5,0.33,0.28,0.5,0.56,0.39,0.33,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Therapy of neuromyelitis optica exacerbations: a </text>
   <text y="346.059" x="62.362,66.358,70.354,73.351,77.347,81.847,85.348,90.352,94.348,98.344,101.341,103.843,108.343,112.339,114.589,118.585,123.085,127.585,130.087,135.091,139.591,142.588,145.09,149.59,154.594,156.844,161.344,164.341,166.591,171.091,175.591,180.091,182.341,186.337,191.341,193.843,197.344,201.844,206.848,210.844,214.345,216.595,223.093,225.595,228.592,233.596,235.846,240.346,244.846,249.346,253.846" svgx:width="0.44,0.44,0.33,0.44,0.5,0.39,0.56,0.44,0.44,0.33,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.28,0.56,0.5,0.33,0.28,0.5,0.56,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.44,0.56,0.28,0.39,0.5,0.56,0.44,0.39,0.25,0.72,0.28,0.33,0.56,0.25,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">retrospective evaluation of 840 episodes with 1168 </text>
   <text y="357.057" x="62.362,65.359,69.355,73.351,77.851,80.848,88.345,92.341,97.345,100.342,102.592,106.588,111.088,115.084,117.586,121.582" svgx:width="0.33,0.44,0.44,0.5,0.33,0.83,0.44,0.56,0.33,0.25,0.44,0.5,0.44,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">treatment cycles</text>
   <text y="368.055" x="62.362,65.359,67.609,74.107,76.609,80.605,83.107,85.609,89.605" svgx:width="0.33,0.25,0.72,0.28,0.44,0.28,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">I Kleiter</text>
   <text y="365.583" x="92.602" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="368.103" x="95.527,97.777,100.027,106.525,108.775,115.273,119.269,123.769,126.271,130.267" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.5,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Gahlen</text>
   <text y="365.583" x="134.766" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="368.103" x="137.691,139.941,142.191,148.689,150.939,156.942,161.442,164.439,166.941,170.442,174.942" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.33,0.28,0.39,0.5,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Borisow</text>
   <text y="365.583" x="181.44" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="368.103" x="184.365,186.615,188.865,195.363,197.613,202.617,205.119,208.62,212.616,217.116,221.112" svgx:width="0.25,0.25,0.72,0.25,0.56,0.28,0.39,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Fischer</text>
   <text y="365.583" x="224.108" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="368.103" x="227.033,229.283,231.533,236.537,238.787,243.791,247.787,252.287" svgx:width="0.25,0.25,0.56,0.25,0.56,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, F Paul</text>
   <text y="365.583" x="254.789" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="368.103" x="257.714,259.964,262.214,268.217" svgx:width="0.25,0.25,0.67,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, C </text>
   <text y="379.101" x="62.36,67.859,70.856,74.852,79.352,82.853" svgx:width="0.61,0.33,0.44,0.5,0.39,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Trebst</text>
   <text y="376.583" x="85.357" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">4</text>
   <text y="379.103" x="88.282,90.532,92.782,99.28,103.276,107.776,110.773,115.273,122.275,126.775,130.771,133.273,135.775,138.277,140.779,144.28,146.53,153.028,157.528,160.03,162.532,166.528,170.524,172.774,177.778,180.28,184.78,189.28,193.78,196.03,202.528,205.525,210.025,214.525,219.025,221.275,224.272,230.77,236.269,244.27,250.768,255.772" svgx:width="0.25,0.25,0.72,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.72,0.5,0.28,0.28,0.44,0.44,0.25,0.56,0.28,0.5,0.5,0.5,0.25,0.72,0.33,0.5,0.5,0.5,0.25,0.33,0.72,0.61,0.89,0.72,0.56,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, Neuromyelitis Optica Study Group (NEMOS)</text>
   <text y="387.583" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="390.103" x="65.287,70.786,75.286,79.786,83.287,86.284,92.782,97.282,99.784,103.78,107.776,111.277,114.778,117.28,119.782,123.778,126.028,131.527,136.027,140.023,144.523,149.023,155.521,157.771,160.021,165.52,170.02,174.016,178.516,183.016,189.514,191.764,194.014,200.512,204.508,208.009,214.507,219.007,223.507,227.503,229.753" svgx:width="0.61,0.5,0.5,0.39,0.33,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.61,0.5,0.44,0.5,0.5,0.72,0.25,0.25,0.61,0.5,0.44,0.5,0.5,0.72,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Ruhr-University Bochum, Bochum, Germany, </text>
   <text y="387.583" x="232.001" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="390.103" x="234.926,240.929,245.429,249.929,253.43,255.932,258.434,262.43" svgx:width="0.67,0.5,0.5,0.39,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Charité </text>
   <text y="401.101" x="62.36,68.858,73.358,75.86,79.856,83.852,87.353,90.854,93.356,95.858,100.358,102.86,106.361,112.859,116.855,121.355,123.857,127.358,129.86,134.36,136.61,142.109,146.105,149.606,152.108,154.61,159.11,161.36,163.61,169.613,173.609,178.109,181.61,186.11,192.113,196.613,200.114,204.11,206.36,212.363,214.865,217.367,221.867,224.369,228.365,232.865,235.367,237.617,243.116,247.112,250.613,254.609,259.109,262.61,266.606,271.106,273.356,279.359,283.355,287.855,290.357,294.353,297.854" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.5,0.28,0.39,0.72,0.44,0.5,0.28,0.39,0.28,0.5,0.25,0.61,0.44,0.39,0.28,0.28,0.5,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.67,0.5,0.39,0.44,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Universitätsmedizin Berlin, NeuroCure Clinical Research Center </text>
   <text y="412.099" x="62.36,66.86,71.36,75.86,78.11,84.113,86.615,89.117,93.617,96.119,100.115,104.615,107.117,109.367,113.867,118.367,122.867,125.117,130.616,134.612,139.112,143.108,146.609,149.111,155.609,159.605,164.105,166.607,171.107,173.609,175.859,183.356,187.856,190.358,192.86,195.362,199.862,202.364,206.36,208.61,213.11,217.106,219.608,223.604,227.105,231.605,235.106,237.608,241.109,243.359,248.858,252.854,256.355,260.351,264.851,268.352,272.348,276.848" svgx:width="0.5,0.5,0.5,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.5,0.5,0.25,0.61,0.44,0.5,0.44,0.39,0.28,0.72,0.44,0.5,0.28,0.5,0.28,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">and Clinical and Experimental Multiple Sclerosis Research </text>
   <text y="423.097" x="62.36,68.363,72.359,76.859,79.361,83.357,85.607,87.857,93.86,97.856,102.356,105.857,110.357,112.859,117.359,121.859,125.855,128.105,130.355,135.854,139.85,143.351,145.853,148.355,152.855,155.105,157.355,163.853,167.849,171.35,177.848,182.348,186.848,190.844,193.094" svgx:width="0.67,0.44,0.5,0.28,0.44,0.25,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.44,0.39,0.28,0.28,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Cente, Neurology, Berlin, Germany, </text>
   <text y="420.583" x="195.345" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="423.103" x="198.27,203.769,207.27,211.266,213.768,217.764,222.264,224.766,229.266,232.767,235.017,240.516,245.016,249.012,253.512,257.508,260.01,262.512,267.012,269.514,273.51,277.506,282.006" svgx:width="0.61,0.39,0.44,0.28,0.44,0.5,0.28,0.5,0.39,0.25,0.61,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Asklepios Fachkliniken </text>
   <text y="434.101" x="62.361,67.86,71.361,75.861,80.361,84.861,88.857,93.357,97.857,102.357,105.858,110.358,112.608,119.106,125.604,130.104,136.602,138.852,141.102,146.106,150.102,154.602,159.102,161.604,164.106,167.607,169.857,172.107,178.605,182.601,186.102,192.6,197.1,201.6,205.596,207.846" svgx:width="0.61,0.39,0.5,0.5,0.5,0.44,0.5,0.5,0.5,0.39,0.5,0.25,0.72,0.72,0.5,0.72,0.25,0.25,0.56,0.44,0.5,0.5,0.28,0.28,0.39,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Brandenburg GmbH, Teupitz, Germany, </text>
   <text y="431.583" x="210.096" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">4</text>
   <text y="434.103" x="213.021,219.519,224.019,228.519,233.019,237.519,241.515,245.511,249.012,251.262,258.759,262.755,267.255,269.757,273.753,278.253,280.755" svgx:width="0.72,0.5,0.5,0.5,0.5,0.44,0.44,0.39,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Hannover Medical </text>
   <text y="445.101" x="62.361,66.861,70.857,75.357,79.857,84.357,86.859,89.109,91.359,97.857,102.357,106.857,111.357,115.857,119.853,123.849,127.35,129.6,131.85,138.348,142.344,145.845,152.343,156.843,161.343" svgx:width="0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.25,0.72,0.5,0.5,0.5,0.5,0.44,0.44,0.39,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">School, Hannover, Germany</text>
   <text y="472.101" x="62.361,68.364,72.864,76.86,81.864,86.364,90.198,94.698,99.702,104.706,109.71,112.707" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="472.101" x="115.11,121.608,125.604,130.104,133.101,137.601,144.603,149.103,153.099,155.601,158.103,160.605,163.107,166.608,169.011,173.511,178.011,180.513,183.015,187.011,191.007,193.41,196.407,202.905,210.906,217.404,220.401,222.804,226.8,231.3,235.8,238.203,240.705,243.207,246.708,249.111,252.612,257.112,261.108,265.104,267.606,270.603,275.103,282.105,284.508,289.008,291.51,295.011" svgx:width="0.72,0.44,0.5,0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.5,0.5,0.28,0.28,0.44,0.44,0.25,0.33,0.72,0.89,0.72,0.33,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.39,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.5,0.78,0.25,0.5,0.28,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Neuromyelitis optica (NMO) and its spectrum dis-</text>
   <text y="483.099" x="62.361,66.861,69.858,74.358,78.354,81.351,84.852,87.102,88.848,91.845,98.343,106.344,112.842,117.846,124.344,127.341,129.591,131.337,133.839,138.339,142.839,145.341,149.337,153.333,155.835,158.337,162.837,165.087,166.833,169.335,173.331,177.831,181.827,184.077,185.823,189.819,192.069,193.815,196.812,200.808,203.31,207.306,211.806,215.307,217.809,222.309,226.809,229.059,230.805,235.305,237.807,241.308,245.304,249.3,252.801,256.797,259.047,260.793,264.789,269.289,273.789,276.786,280.287,284.283,286.533,288.783,290.529,293.526,298.026" svgx:width="0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.33,0.72,0.89,0.72,0.56,0.72,0.33,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.44,0.5,0.44,0.25,0.55,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.55,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">orders (NMOSD) typically take a relapsing disease course. In </text>
   <text y="494.097" x="62.361,66.357,70.857,77.859,82.359,86.355,89.352,91.854,95.355,99.855,104.355,106.605,108.063,110.565,115.065,117.315,118.773,125.775,130.275,132.777,135.279,137.781,142.281,144.783,148.779,151.029,152.487,155.988,159.984,162.486,166.482,169.479,173.979,177.48,179.982,183.483,185.733,187.983,189.441,193.437,197.937,201.933,205.929,209.925,212.922,217.422,221.418,223.92,226.422,230.922,235.422,238.923,241.173,242.631,246.627,249.624,253.62,255.87,257.328,261.828,264.825,267.327,271.323,275.823,278.073,279.531,286.533,291.033,294.03,298.026" svgx:width="0.44,0.5,0.78,0.5,0.44,0.33,0.28,0.39,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.44,0.5,0.44,0.44,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.78,0.5,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">comparison to multiple sclerosis, exacerbations are often more </text>
   <text y="505.095" x="62.361,65.862,69.858,74.358,78.354,81.351,85.347,87.597,89.964,92.961,96.957,100.458,104.958,109.458,113.958,118.458,120.825,123.327,127.323,130.824,134.325,136.692,139.194,143.694,146.061,148.563,153.063,157.059,160.056,164.052,168.552,173.052,175.419,179.415,183.915,188.415,190.782,193.284,197.28,201.276,205.776,209.772,212.139,216.135,218.502,221.499,225.495,228.996,231.498,235.998,240.498,244.494,246.996,249.363,253.863,257.859,260.856,263.358,267.354,269.856,272.358,274.608,276.975,283.473,285.975,290.475,294.975" svgx:width="0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.25,0.28,0.44,0.39,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.44,0.44,0.5,0.44,0.25,0.44,0.25,0.33,0.44,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.28,0.25,0.25,0.72,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">severe, respond less to therapy and leave a residual deficit. High-</text>
   <text y="516.093" x="62.361,66.861,71.361,74.862,78.858,81.009,84.006,90.342,92.493,95.994,98.496,102.492,105.489,109.989,112.491,116.991,119.142,121.644,126.144,130.14,133.137,137.133,141.633,146.133,148.284,151.281,157.779,164.277,167.274,172.278,175.275,177.426,181.422,185.922,190.422,192.573,197.073,199.575,203.571,207.072,214.074,218.07,220.221,224.217,228.717,232.713,237.213,241.209,245.709,250.209,254.205,256.356,259.353,264.357,269.856,275.355,281.853,284.85,287.001,290.997,293.994,297.99" svgx:width="0.5,0.5,0.39,0.44,0.25,0.33,0.72,0.25,0.39,0.28,0.44,0.33,0.5,0.28,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.33,0.72,0.72,0.33,0.56,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.44,0.39,0.78,0.44,0.25,0.44,0.5,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.33,0.56,0.61,0.61,0.72,0.33,0.25,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">dose IV steroid therapy (HD-S) and plasma exchange (PLEX) are </text>
   <text y="527.091" x="62.361,65.358,69.354,73.35,77.85,84.852,91.854,95.85,100.35,104.85,108.846,113.346,115.596,118.098,121.095,125.091,129.087,131.589,138.591,142.587,147.087,149.589,153.09,155.34,159.84,162.837,165.087,171.585,179.586,186.084,188.334,191.331,195.327,197.829,201.825,206.325,209.826,213.822,217.323" svgx:width="0.33,0.44,0.44,0.5,0.78,0.78,0.44,0.5,0.5,0.44,0.5,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25,0.72,0.89,0.72,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">recommended treatments of NMO relapses.</text>
   <text y="538.089" x="62.361,69.363,74.367,77.364,81.36,85.356,88.353,90.855,95.355,99.351,102.852,105.849" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="538.089" x="110.259,115.128,119.628,121.878,124.038,128.538,132.534,136.035,140.031,143.028,145.53,150.03,154.026,156.276,158.436,161.433,164.43,168.426,172.926,177.426,181.422,185.922,189.918,194.418,196.668,198.828,202.824,207.324,211.824,214.074,216.234,219.735,223.731,228.231,232.731,236.727,241.227,245.223,249.219,251.469,253.629,258.129,261.126,263.376,265.536,268.038,272.538,276.534,279.531,283.527,288.027,290.529,294.525,298.026" svgx:width="0.61,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.33,0.28,0.5,0.44,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To describe frequency and sequence of therapies </text>
   <text y="549.087" x="62.361,66.861,70.362,74.358,78.858,81.279,84.276,88.776,91.773,94.194,100.692,108.693,115.191,117.612,120.609,124.605,127.107,131.103,135.603,139.104,143.1,146.601,149.022,153.018,157.518,162.018,164.439,166.941,171.441,173.862,177.858,182.358,186.354,188.856,193.356,197.352,199.854,203.85,206.271,208.773,213.273,217.269,219.69,222.687,226.683,233.685,236.187,239.688,243.189,245.691,250.191,254.691,257.112,260.613,263.115,267.111,269.613,274.113,277.614,280.035,284.535,289.035,293.535,298.035" svgx:width="0.5,0.39,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.72,0.89,0.72,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">used for NMO relapses and to evaluate the remission status upon </text>
   <text y="560.085" x="62.361,64.863,69.363,73.359,76.86,80.856,83.106,85.608,90.108,94.104,97.101,101.097,105.597,108.099,112.095,115.596" svgx:width="0.28,0.5,0.44,0.39,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">these therapies.</text>
   <text y="571.083" x="62.361,70.857,74.853,77.85,82.854,87.354,92.358,95.859,98.856" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="571.083" x="101.358,107.856,111.357,113.859,118.359,122.859,125.361,129.357,131.859,136.359,140.355,142.857,145.359,149.859,154.359,157.356,163.854,166.356,170.856,174.852,177.354,180.351,184.347,188.847,191.349,194.85,197.352,200.349,204.849,207.351,210.348,216.846,223.344,229.257,231.507,236.007,240.003,247.005,251.505,255.006,258.003,262.503,266.499,269.001,271.251,275.751,279.747,282.744,284.994,287.496,293.994,297.99" svgx:width="0.72,0.39,0.28,0.5,0.5,0.25,0.44,0.25,0.5,0.44,0.28,0.28,0.5,0.5,0.33,0.72,0.28,0.5,0.44,0.25,0.33,0.44,0.5,0.28,0.39,0.28,0.33,0.5,0.25,0.33,0.72,0.72,0.72,0.25,0.5,0.44,0.78,0.5,0.39,0.33,0.5,0.44,0.28,0.25,0.5,0.44,0.33,0.25,0.25,0.72,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Using a nation-wide registry (www.nemos-net.de), we </text>
   <text y="582.081" x="62.361,65.358,69.354,71.856,74.853,79.353,82.854,87.354,91.35,95.346,97.848,100.35,104.85,108.846,111.348,115.848,118.098,118.872,121.869,125.865,130.365,132.867,136.863,143.361,147.357,151.857,154.107,154.881,157.878,161.874,165.87,170.37,173.367,177.867,181.368,183.618,184.392,188.892,191.889,194.139,194.913,201.411,209.412,215.91,218.16,218.934,223.434,227.43,229.932,232.434,236.43,240.93,243.432,246.933,249.183,249.957,256.455,258.957,261.459,265.959,268.209,268.983,272.979,275.229,276.003,279.504,282.006,286.002,290.502,295.002" svgx:width="0.33,0.44,0.28,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.33,0.44,0.5,0.28,0.44,0.72,0.44,0.5,0.25,0.55,0.33,0.44,0.44,0.5,0.33,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.89,0.72,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.28,0.44,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">retrospectively reviewed records of NMO patients with a stand-</text>
   <text y="593.079" x="62.361,66.357,69.354,73.854,76.356,80.352,84.348,88.848,91.098,92.871,96.867,101.367,105.363,107.865,112.365,116.361,118.863,121.365,125.865,130.365,132.615,134.388,137.385,141.885,144.882,151.884,154.134,155.916,158.418,162.918,165.168,166.95,170.946,174.447,177.948,181.944,185.445,188.946,191.196,192.969,197.469,201.465,208.467,212.967,217.467,220.464,224.46,228.96,233.46,235.962,239.958,242.208,243.981,247.977,252.477,256.977,259.227,261.009,265.509,268.011,272.007,276.507,281.007,285.507,289.008,291.51,294.012,298.008" svgx:width="0.44,0.33,0.5,0.28,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.33,0.78,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.25,0.55,0.5,0.44,0.78,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.5,0.5,0.39,0.28,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ardized evaluation form to assess demographic and diagnostic </text>
   <text y="604.077" x="62.361,66.861,70.857,73.359,77.355,79.605,81.855,83.223,86.22,90.216,92.718,96.714,101.214,104.715,108.711,112.212,114.462,115.83,118.827,122.823,125.325,127.827,132.327,134.829,138.825,142.821,145.323,147.573,148.941,152.937,157.437,161.937,165.933,169.929,172.926,176.922,181.422,185.418,189.414,191.664,193.914,195.282,198.783,202.779,207.279,211.275,214.272,216.774,219.276,223.191,225.441,227.691,229.059,231.561,236.061,240.057,243.054,247.05,251.55,254.052,258.048,261.549,264.546,266.796,269.046,270.414,274.41,278.91,283.41,285.66,287.028,289.53,294.03,298.026" svgx:width="0.5,0.44,0.28,0.44,0.25,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.33,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.5,0.5,0.44,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.28,0.28,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.28,0.44,0.39,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">data, relapses (clinical appearance, severity, therapies), and the </text>
   <text y="615.075" x="62.361,65.862,70.362,74.862,77.859,80.361,83.358,85.86,89.856,92.853,99.855,102.591,105.588,109.584,116.586,119.088,122.589,126.09,128.592,133.092,137.592,140.337,143.838,146.34,150.336,152.838,157.338,160.839,163.575,166.572,170.568,173.07,177.066,181.566,184.311,188.307,191.808,194.544,198.54,201.042,203.544,208.044,212.04,215.037,217.782,221.778,226.278,233.28,237.78,240.282,244.278,246.78,250.776,253.026,255.762,258.264,262.764,266.76,271.26,278.262,282.762,285.264,289.26,291.762,295.758,298.008" svgx:width="0.39,0.5,0.5,0.33,0.28,0.33,0.28,0.44,0.33,0.78,0.25,0.33,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.33,0.44,0.28,0.44,0.5,0.25,0.44,0.39,0.25,0.44,0.28,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.25,0.25,0.28,0.5,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">short-term remission status rated as either complete, incomplete, </text>
   <text y="626.073" x="62.361,66.861,71.361,75.861,79.857,82.107,84.357,87.336,91.836,94.833,97.083,100.062,107.064,109.566,113.067,116.568,119.07,123.57,128.07,130.32,133.299,137.799,141.795,144.297,148.293,150.543,153.522,156.519,164.52,171.018,174.015,176.265,178.515,181.332,189.108,193.104,195.354,198.333,200.835,205.335,209.331,211.833,216.333,220.833,224.829,229.329,231.579,234.558,238.554,241.056,243.558,245.808,248.787,253.287,257.283,259.785,262.287,266.283,270.783,273.285,276.786,279.036,282.015,288.513,291.015,293.517,298.017" svgx:width="0.5,0.5,0.5,0.44,0.25,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.33,0.89,0.72,0.33,0.25,0.25,0.55,0.94,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">none, or missing data (MD). We included all patients with </text>
   <text y="637.071" x="62.361,70.497,72.999,77.499,81.999,85.995,88.992,92.988,97.488,101.988,106.488,108.999,115.497,123.498,129.996,132.516,137.016,140.013,142.524,146.52,151.02,155.52,159.516,164.016,168.516,171.513,174.015,178.515,181.512,186.012,189.009,193.509,198.009,201.51,204.012,206.514,209.016,213.516,217.512,220.023,226.521,234.522,241.02,246.024,252.522,255.033,261.531,266.031,270.531,273.051,277.551,281.547,286.047,288.558,293.499,297.999" svgx:width="0.94,0.28,0.5,0.5,0.44,0.33,0.44,0.5,0.5,0.5,0.25,0.72,0.89,0.72,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.28,0.5,0.33,0.5,0.33,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.72,0.89,0.72,0.56,0.72,0.25,0.72,0.5,0.5,0.25,0.5,0.44,0.5,0.25,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Wingerchuk NMO or aquaporin-4-positive NMOSD who had ≥1 </text>
   <text y="648.069" x="62.361,65.358,69.354,71.856,75.852,80.352,83.853,87.849,90.099,91.215,97.713,100.215,102.717,107.217,109.467,110.592,114.093,118.593,121.428,124.425,126.927,130.923,133.425,137.421,141.921,144.423,146.673,147.789,152.289,156.789,160.785,165.285,172.287,176.283,180.783,183.285,187.281,189.783,192.285,196.785,201.285,203.535,205.785,206.901,211.905,215.901,218.403,220.905,224.901,229.401,231.903,235.404,237.654,238.779,243.279,246.276,248.526,249.642,252.639,256.635,259.137,263.133,267.633,271.134,275.13,278.631,280.881,281.997,288.495,290.997,293.499,297.999" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.39,0.5,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.55,0.5,0.5,0.44,0.5,0.78,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.56,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapse with sufficient documentation. Patients or relapses with </text>
   <text y="659.067" x="62.361,64.863,69.363,72.864,77.364,80.199,83.196,85.698,89.694,92.196,96.192,100.692,103.194,105.444,109.944,113.94,116.442,120.438,122.688,129.186,133.182,136.179,140.175,142.425,146.421,150.921,154.917,157.419,161.919,166.419,170.415,174.915" svgx:width="0.28,0.5,0.39,0.5,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.44,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">insufficient data were excluded.</text>
   <text y="670.065" x="62.361,68.859,72.855,76.356,81.36,83.862,86.859,90.36,93.357" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="670.065" x="95.571,103.347,107.343,109.557,112.059,116.559,120.555,125.055,127.557,130.059,133.056,135.558,139.554,144.054,146.268,150.768,155.268,159.768,161.982,166.482,170.478,172.98,175.482,179.478,183.978,186.48,189.981,192.195,195.192,199.692,204.192,208.692,210.906,217.404,225.405,231.903,234.153,236.367,240.867,245.367,247.581,254.079,262.08,268.578,273.582,280.08,282.33,284.544,289.044,293.544,298.044" svgx:width="0.94,0.44,0.25,0.28,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.5,0.25,0.72,0.89,0.72,0.25,0.25,0.5,0.5,0.25,0.72,0.89,0.72,0.56,0.72,0.25,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We identified 186 patients (143 NMO, 43 NMOSD, 152 </text>
   <text y="681.063" x="62.361,65.358,69.354,76.356,80.352,82.854,86.85,89.847,92.691,99.189,101.691,104.193,108.693,111.537,115.533,118.377,120.879,125.379,127.881,131.877,134.379,137.223,141.723,144.72,147.564,151.731,156.231,160.731,165.231,168.075,171.072,175.068,177.57,181.566,186.066,189.567,193.563,197.064,199.314,202.158,210.159,214.155,218.151,222.651,225.495,229.491,233.991,237.987,240.831,244.827,247.329,250.173,254.673,257.175,260.676,264.672,268.668,272.169,276.165,279.009,283.509,288.009,291.51,295.506,298.008" svgx:width="0.33,0.44,0.78,0.44,0.28,0.44,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.25,0.89,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.44,0.28,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.39,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">female) with a total of 1124 relapses. Mean age at disease onset </text>
   <text y="692.061" x="62.361,68.859,72.855,76.356,78.39,82.89,87.39,89.424,93.924,97.92,101.916,104.913,108.414,110.664,112.698,119.7,123.696,127.692,132.192,134.226,138.726,143.226,146.223,150.219,152.721,155.223,159.723,164.223,166.257,170.757,173.754,175.788,178.785,183.285,185.787,188.289,192.789,199.287,202.284,206.784,211.284,213.318,217.818,219.852,224.352,228.348,232.344,235.341,238.842,241.092,242.964,248.463,252.963,256.959,258.993,262.989,267.489,271.989,276.489,280.485,282.987,285.489,289.485,293.481,297.981" svgx:width="0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.28,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was 40 years, mean duration of follow-up 7 years. The annualized </text>
   <text y="703.059" x="62.361,65.358,69.354,71.856,75.852,80.352,83.853,87.849,90.099,91.323,94.32,98.316,100.818,104.814,107.064,108.288,114.786,118.782,122.283,124.533,125.757,130.257,132.507,137.007,141.507,143.757,144.981,147.978,152.478,156.978,164.475,166.725,167.949,173.952,176.949,179.199,180.423,184.923,187.173,191.673,196.173,199.17,203.67,205.92,210.42,214.92,217.917,220.167,222.417,223.641,228.141,232.641,237.141,239.391,240.615,245.115,249.111,251.613,254.115,258.111,262.611,265.113,268.614,270.864,272.088,276.588,280.584,285.084,287.334,288.558,293.499,297.999" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.5,0.25,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.83,0.25,0.55,0.67,0.33,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.55,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapse rate was 1.06 (95% CI 0.96-1.12). 150 patients had ≥1 </text>
   <text y="714.057" x="62.361,66.861,71.361,73.863,76.365,80.361,82.611,85.14,89.64,93.636,98.136,101.133,103.635,106.137,108.639,112.14,114.39,116.919,119.916,126.414,132.912,135.909,138.159,140.688,144.684,149.184,153.684,155.934,158.463,162.963,167.463,171.963,174.213,176.742,181.242,185.238,187.74,190.242,194.238,198.738,201.24,204.741,206.991,209.52,214.02,218.016,222.516,224.766,227.295,232.236,236.736,238.986,241.515,248.517,253.017,257.013,259.515,262.017,264.519,267.021,270.522,272.772,275.301,278.298,286.299,292.797,295.794,298.044" svgx:width="0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.55,0.33,0.72,0.72,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.55,0.5,0.25,0.55,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.33,0.89,0.72,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">optic neuritis (ON) and 179 patients had ≥1 myelitis (MY). </text>
   <text y="725.055" x="62.361,67.86,72.36,74.862,78.363,82.863,87.363,91.359,94.86,97.254,101.754,104.751,107.145,109.647,113.148,117.648,120.15,124.146,126.648,130.644,135.144,137.538,145.539,151.704,154.098,157.095,161.595,166.095,173.592,176.589,178.983,185.481,189.477,192.474,196.47,198.864,205.866,210.366,213.363,217.359,219.753,222.75,225.747,229.743,234.243,238.743,242.739,247.239,249.741,252.135,254.637,259.137,263.133,267.633,270.027,272.529,276.03,280.53,283.032,287.028,289.53,293.526,298.026" svgx:width="0.61,0.5,0.28,0.39,0.5,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.89,0.72,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.72,0.44,0.33,0.44,0.25,0.78,0.5,0.33,0.44,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.28,0.5,0.44,0.5,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Episodes of isolated MY (59%) were more frequent than isolated </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 336.300 L347.250 336.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,316.514,323.012,325.262,326.558,329.555,334.055,338.555,346.052,349.049,351.299,353.549,354.845,362.846,369.344,374.42,380.918,387.416,389.666,390.962,393.959,398.459,402.959,410.456,413.453,415.703,417.953,419.249,423.245,427.745,432.245,434.495,435.791,440.291,442.793,447.293,451.289,454.286,456.536,457.832,462.332,465.329,469.325,472.826,476.822,481.322,483.824,487.82,490.322,492.824,497.324,501.824,505.325,507.575,508.871,511.868,516.368,523.865,526.862,529.112,531.362,532.658,539.156,545.654" svgx:width="0.72,0.72,0.25,0.55,0.33,0.5,0.5,0.83,0.33,0.25,0.25,0.55,0.89,0.72,0.56,0.72,0.72,0.25,0.55,0.33,0.5,0.5,0.83,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.33,0.5,0.83,0.33,0.25,0.25,0.55,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ON (28%), MY+ON (10%), and other presentations (1%). ON </text>
   <text y="88.101" x="310.016,316.514,320.51,324.011,326.009,330.509,335.009,337.511,340.013,344.009,346.511,350.507,353.504,357.5,360.002,362.0,364.502,369.002,371.0,375.5,380.0,387.497,389.495,393.491,397.991,402.491,404.489,408.989,411.491,413.993,417.989,420.491,424.487,427.484,431.48,433.982,435.971,438.473,442.973,444.971,449.471,453.971,461.468,463.718,465.221,471.719,474.716,477.218,481.214,484.211,486.209,490.205,494.705,498.701,501.203,505.703,509.204,511.706,516.206,520.706,522.704,527.204,530.201,532.199,536.699,541.199,545.699" svgx:width="0.72,0.44,0.39,0.25,0.5,0.5,0.28,0.28,0.44,0.28,0.44,0.33,0.44,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.28,0.44,0.28,0.44,0.33,0.44,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.25,0.72,0.33,0.28,0.44,0.33,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was unilateral in 82% and bilateral in 18%. After exclusion of 284 </text>
   <text y="99.099" x="310.016,313.013,317.009,319.511,323.507,328.007,331.508,335.504,339.005,341.552,346.052,350.552,354.548,357.095,359.597,364.097,366.644,369.146,373.646,377.147,381.647,384.482,387.479,389.981,393.977,396.479,400.475,404.975,407.477,410.024,414.524,418.52,421.022,425.018,427.268,429.815,434.315,438.815,443.315,446.312,449.813,452.315,456.311,460.811,465.311,469.307,472.304,476.804,479.351,483.851,486.848,489.395,493.895,498.395,500.942,503.444,507.944,511.94,514.937,518.933,523.433,527.348,529.598,532.145,536.645,541.145,545.645" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.39,0.5,0.33,0.33,0.28,0.44,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.44,0.25,0.25,0.5,0.5,0.5,0.33,0.39,0.28,0.44,0.5,0.5,0.44,0.33,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapses due to insufficient data, non-standard or no therapy, 840 </text>
   <text y="110.097" x="310.016,313.013,317.009,319.511,323.507,328.007,331.508,335.504,339.005,341.255,343.316,349.814,352.316,354.818,359.318,361.568,363.629,367.625,369.875,371.936,374.438,378.938,381.44,385.436,387.938,390.188,392.249,396.749,399.746,401.996,404.057,408.224,412.724,417.224,421.724,423.974,426.035,428.537,431.534,435.53,439.526,442.028,449.03,453.026,457.526,460.028,462.278,464.339,468.335,472.835,476.831,479.333,483.329,486.83,489.08,491.141,497.639,501.635,504.632,508.628,510.878,512.939,516.935,520.436,523.937,527.933,531.434,534.935,538.931,543.431,545.681" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.28,0.5,0.28,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.44,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapses with a total of 1168 treatment cycles were assessed. </text>
   <text y="121.095" x="310.016,315.515,320.015,324.011,327.512,331.508,333.767,337.763,342.263,349.265,353.765,356.762,359.264,362.765,366.761,371.261,373.52,380.018,386.516,389.513,394.517,396.776,399.773,404.273,409.349,413.849,418.349,422.849,425.846,428.096,430.355,435.359,440.858,446.357,452.855,455.114,458.111,462.611,467.687,472.187,476.687,481.187,484.184,486.434,488.693,491.195,498.197,505.199,509.699,514.199,518.699,522.695,527.195,530.696,535.196,538.193,542.693" svgx:width="0.61,0.5,0.44,0.39,0.44,0.25,0.44,0.5,0.78,0.5,0.33,0.28,0.39,0.44,0.5,0.25,0.72,0.72,0.33,0.56,0.25,0.33,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.25,0.56,0.61,0.61,0.72,0.25,0.33,0.5,0.56,0.5,0.5,0.5,0.33,0.25,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.44,0.5,0.39,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">These comprised HD-S (n=856), PLEX (n=192), immunoadsorp-</text>
   <text y="132.093" x="310.016,312.518,315.02,319.52,324.02,325.856,328.853,333.353,338.429,342.929,347.429,350.426,352.676,354.512,357.014,361.514,364.016,367.013,371.009,373.511,378.011,382.007,386.003,389.999,392.501,394.337,397.838,400.34,404.336,407.333,411.833,414.335,418.835,422.336,424.172,427.169,431.669,436.745,441.245,445.745,448.742,450.992,452.828,455.33,459.83,462.332,465.329,469.325,473.825,477.821,482.321,486.821,491.321,494.822,496.658,499.16,506.162,513.164,517.664,522.164,526.664,531.164,533.666,538.166,542.666" svgx:width="0.28,0.28,0.5,0.5,0.25,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.28,0.5,0.28,0.33,0.44,0.28,0.5,0.44,0.44,0.44,0.28,0.25,0.39,0.28,0.44,0.33,0.5,0.28,0.5,0.39,0.25,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.28,0.5,0.28,0.33,0.44,0.5,0.44,0.5,0.5,0.5,0.39,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.5,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion (n=38), intrathecal steroids (n=23), intravenous immunoglob-</text>
   <text y="143.091" x="310.016,314.516,317.018,319.52,324.02,327.521,329.771,332.381,335.378,339.878,344.954,349.454,353.954,356.951,359.201,361.451,364.061,368.057,372.557,377.057,379.307,381.917,386.417,388.919,393.419,397.415,400.412,403.913,406.163,408.773,411.77,416.27,421.346,425.846,430.346,433.343,435.593,437.843,440.453,445.457,447.959,450.956,454.457,456.959,459.956,462.458,464.96,469.46,473.456,475.706,478.316,480.818,483.815,487.811,491.807,494.309,501.311,505.307,509.807,512.309,514.559,517.169,519.671,524.171,528.671,533.171,537.167,541.163,545.663" svgx:width="0.5,0.28,0.28,0.5,0.39,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.33,0.39,0.25,0.55,0.33,0.5,0.56,0.5,0.5,0.33,0.25,0.25,0.55,0.56,0.28,0.33,0.39,0.28,0.33,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ulins (n=21), and others (n=51). First-line treatment induced </text>
   <text y="154.089" x="310.016,314.012,318.512,325.514,330.014,332.516,336.512,339.014,343.01,345.143,348.14,352.136,359.138,361.64,365.141,368.642,371.144,375.644,380.144,382.277,384.779,389.279,391.412,395.912,400.412,407.909,410.159,412.292,414.794,419.294,423.29,427.79,434.792,439.292,441.794,445.79,448.292,452.288,454.421,456.923,461.423,463.556,468.056,472.556,480.053,482.303,484.436,488.432,492.932,497.432,499.565,504.065,508.565,510.698,513.695,517.691,524.693,527.195,530.696,534.197,536.699,541.199,545.699" svgx:width="0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.25,0.33,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.25,0.28,0.5,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.33,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">complete remission in 17%, incomplete in 60%, and no remission </text>
   <text y="165.087" x="310.016,312.518,317.018,318.962,323.462,327.962,335.459,337.403,340.4,344.9,352.397,354.341,362.342,368.84,371.837,374.087,376.031,381.035,384.032,388.028,392.528,397.028,401.024,405.524,409.52,414.02,415.964,420.464,423.461,425.405,428.402,432.398,434.9,438.896,443.396,446.897,450.893,454.394,456.338,459.335,463.331,467.831,472.331,474.833,477.83,480.332,484.832,489.332,491.276,495.272,497.216,500.717,504.713,508.709,513.209,517.709,522.209,524.459,526.403,528.905,533.405,535.907,538.904,543.404,545.654" svgx:width="0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.33,0.5,0.83,0.25,0.89,0.72,0.33,0.25,0.25,0.56,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.33,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.25,0.44,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.25,0.25,0.28,0.5,0.28,0.33,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in 16% (7% MD). Frequency of relapses requiring a second, third, </text>
   <text y="176.085" x="310.016,313.013,317.513,320.51,323.012,327.512,329.762,332.039,336.035,340.535,345.035,347.312,350.309,352.811,355.808,358.31,362.81,365.087,367.589,370.091,374.591,378.587,380.864,383.366,387.866,391.862,394.859,398.855,403.355,407.855,410.132,416.63,420.626,423.623,427.619,429.896,434.396,438.896,446.393,448.643,450.92,455.42,462.917,465.167,467.444,471.944,479.441,481.691,483.968,488.468,495.965,498.215,500.492,503.489,507.485,510.986,515.486,519.482,523.478,525.98,528.482,532.982,536.978,539.48,543.395,545.645" svgx:width="0.33,0.5,0.33,0.28,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.33,0.28,0.33,0.28,0.5,0.25,0.28,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.83,0.25,0.25,0.5,0.83,0.25,0.25,0.5,0.83,0.25,0.25,0.5,0.83,0.25,0.25,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">forth, and fifth line therapy were 30%, 8%, 1%, 1%, respectively. </text>
   <text y="187.083" x="310.016,316.514,319.511,322.013,326.009,329.006,331.472,333.974,338.474,342.47,344.936,347.438,351.434,354.935,357.437,359.903,362.405,365.402,369.398,373.394,375.896,382.898,386.894,391.394,393.896,396.362,400.358,404.858,408.854,411.356,415.352,417.602,420.068,424.568,429.068,436.565,439.031,443.531,446.528,448.994,451.991,455.987,458.489,462.485,466.985,470.486,474.482,477.983,480.449,483.95,488.45,492.95,499.448,503.444,507.944,510.41,514.406,518.906,525.908,530.408,532.91,536.906,539.408,543.404,545.654" svgx:width="0.72,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.39,0.28,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.44,0.5,0.44,0.28,0.44,0.25,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.44,0.5,0.78,0.5,0.28,0.44,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">After the last treatment cycle, 19% of relapses showed complete, </text>
   <text y="198.081" x="310.016,314.516,319.016,326.513,328.763,330.419,334.919,338.915,341.912,344.414,346.916,350.912,353.414,355.664,357.914,359.57,363.566,368.066,372.566,374.816,376.472,380.972,388.469,390.719,392.375,396.875,401.375,403.625,405.281,408.278,412.274,419.276,421.778,425.279,428.78,431.282,435.782,440.282,442.532,444.188,447.185,451.685,459.182,461.432,463.088,471.089,477.587,480.584,482.834,485.084,486.74,492.743,496.739,503.741,506.243,509.744,513.245,515.747,520.247,524.747,526.997,528.653,531.65,535.646,538.148,542.144,545.645" svgx:width="0.5,0.5,0.83,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.44,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.83,0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.83,0.25,0.55,0.89,0.72,0.33,0.25,0.25,0.55,0.67,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">67% partial, and 7% no remission (7% MD). Remission rates </text>
   <text y="209.079" x="310.016,316.514,320.51,323.507,327.503,329.429,333.929,336.431,340.931,345.431,349.427,352.424,354.35,357.347,361.847,364.844,366.77,371.774,377.273,382.772,389.27,391.196,395.192,399.692,404.192,406.118,408.62,415.622,422.624,427.124,431.624,436.124,440.12,444.62,448.121,452.621,455.618,460.118,462.62,465.122,469.622,474.122,476.048,480.044,484.544,491.546,496.046,500.042,503.039,507.035,511.535,513.461,515.963,520.463,522.389,528.887,535.385,538.382,543.386,545.636" svgx:width="0.72,0.44,0.33,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.33,0.5,0.33,0.25,0.56,0.61,0.61,0.72,0.25,0.44,0.5,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.44,0.5,0.39,0.5,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.72,0.33,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were higher for PLEX and immunoadsorption compared to HD-S. </text>
   <text y="220.077" x="310.016,316.514,323.012,325.262,328.259,332.255,335.756,340.256,344.756,349.256,353.756,357.752,362.252,364.502,368.003,370.505,375.005,379.505,382.007,385.004,387.506,391.502,395.498,399.998,402.5,405.002,409.502,411.752,416.252,420.248,422.75,425.252,429.248,432.245,434.495,436.997,441.497,445.493,449.993,452.243,460.244,465.581" svgx:width="0.72,0.72,0.25,0.33,0.44,0.39,0.5,0.5,0.5,0.5,0.44,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.89,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ON responded significantly better than MY.</text>
   <text y="231.075" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="231.075" x="361.838,368.336,376.337,382.835,385.148,389.144,393.644,398.144,400.457,406.955,414.956,421.454,426.458,432.956,435.269,439.265,443.765,447.761,451.757,455.753,458.75,463.25,467.246,469.748,472.25,476.75,481.25,484.751,487.064,491.06,494.057,498.053,500.366,503.363,506.36,510.356,514.856,519.356,523.352,527.852,530.354,532.667,536.663,541.163,545.663" svgx:width="0.72,0.89,0.72,0.25,0.44,0.5,0.5,0.25,0.72,0.89,0.72,0.56,0.72,0.25,0.44,0.5,0.44,0.44,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.44,0.33,0.44,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMO and NMOSD exacerbations are frequent and </text>
   <text y="242.073" x="310.016,314.516,318.512,323.012,327.008,329.546,334.046,338.546,343.046,346.043,348.581,351.578,355.574,362.576,365.078,368.579,372.08,374.582,379.082,383.582,386.12,389.117,393.113,395.615,399.611,403.112,405.362,407.9,410.402,414.902,417.44,421.94,425.936,428.933,431.435,433.937,437.933,442.433,444.935,448.931,451.928,454.466,462.467,467.804,470.054,472.43,477.614,480.611,484.607,488.603,491.105,498.107,502.103,506.603,509.105,511.643,515.144,517.646,520.643,524.639,527.141,531.137,535.637,538.139,542.135,545.636" svgx:width="0.5,0.44,0.5,0.44,0.25,0.5,0.5,0.5,0.33,0.25,0.33,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.33,0.44,0.28,0.44,0.39,0.25,0.25,0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.28,0.44,0.33,0.25,0.89,0.72,0.25,0.25,0.61,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">have poor remission rates, in particular MY. Treatment strategies </text>
   <text y="253.071" x="310.016,314.012,317.009,321.005,323.255,324.029,328.529,331.031,335.531,340.031,342.533,347.033,349.283,350.057,354.557,358.553,361.055,365.051,368.048,372.548,377.048,381.044,385.544,389.54,394.04,398.54,402.041,404.291,405.065,409.061,413.561,418.061,420.311,421.085,427.583,434.081,437.078,442.082,444.332,445.106,449.102,453.602,458.102,460.352,461.126,466.13,471.629,477.128,483.626,485.876,486.65,493.652,498.152,501.653,504.155,506.405,507.179,511.175,515.675,522.677,529.679,534.179,538.679,541.181,545.681" svgx:width="0.44,0.33,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.5,0.5,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.72,0.33,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.61,0.61,0.72,0.25,0.55,0.78,0.5,0.39,0.28,0.25,0.55,0.44,0.5,0.78,0.78,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">are highly heterogeneous and HD-S and PLEX most commonly </text>
   <text y="264.069" x="310.016,314.516,318.017,322.013,326.513,328.763,331.013,331.877,337.376,340.877,344.873,348.869,351.371,355.367,357.869,360.371,364.871,369.371,371.621,372.485,376.985,379.982,382.232,383.096,386.093,390.089,392.591,396.587,401.087,404.588,408.584,410.834,411.698,414.2,418.7,422.696,425.693,429.689,434.189,438.689,440.939,441.803,444.305,451.307,455.807,458.804,463.304,467.804,471.8,475.301,477.551,478.415,481.412,485.408,492.41,494.912,498.413,501.914,504.416,508.916,513.416,515.666,516.53,519.032,523.532,525.782,526.646,530.147,534.647,541.649,545.645" svgx:width="0.5,0.39,0.44,0.5,0.25,0.25,0.55,0.61,0.39,0.44,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.28,0.78,0.5,0.33,0.5,0.5,0.44,0.39,0.25,0.55,0.33,0.44,0.78,0.28,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.5,0.78,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">used. Escalation of relapse therapy improves remission in some </text>
   <text y="275.067" x="310.016,314.516,318.512,321.014,323.516,327.512,332.012,334.514,338.015" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients.</text>
   <text y="302.067" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P641</text>
   <text y="313.065" x="310.016,316.514,319.016,321.518,326.522,329.024,333.02,337.52,340.022,342.272,346.772,351.776,356.78,359.03,363.026,367.526,372.53,375.032,379.532,382.034,386.534,391.034,393.536,397.532,402.032,404.534,406.784,411.788,415.784,420.284,423.281,425.783,428.285,432.281,435.782,438.032,442.532,445.529,447.779,452.279,457.283,460.28,464.276,468.272,470.774,475.274,479.27,481.52,486.02,488.522,492.023,497.027,501.527,504.029" svgx:width="0.72,0.28,0.28,0.56,0.28,0.44,0.5,0.28,0.25,0.5,0.56,0.56,0.25,0.44,0.5,0.56,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.56,0.44,0.5,0.33,0.28,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.56,0.33,0.44,0.44,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.56,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Clinical and radiological profiles of anterior visual </text>
   <text y="324.063" x="310.016,315.02,319.52,322.517,327.521,334.019,338.519,343.019,345.269,347.771,352.775,357.275,361.775,364.277,368.777,372.773,380.27,384.266,389.27,392.267,394.517,397.019,402.023,404.273,409.277,413.273,418.277,422.273,426.773,434.27,438.77,442.766,445.268,447.77,450.767,453.269,456.77,459.02,463.52,468.524,471.521,474.023,478.019" svgx:width="0.56,0.5,0.33,0.56,0.72,0.5,0.5,0.25,0.28,0.56,0.5,0.5,0.28,0.5,0.44,0.83,0.44,0.56,0.33,0.25,0.28,0.56,0.25,0.56,0.44,0.56,0.44,0.5,0.83,0.5,0.44,0.28,0.28,0.33,0.28,0.39,0.25,0.5,0.56,0.33,0.28,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">pathway involvement in neuromyelitis optica</text>
   <text y="335.061" x="310.016,313.013,315.263,321.761,325.757,332.255,336.251,340.247,344.747" svgx:width="0.33,0.25,0.72,0.44,0.72,0.44,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">I Kawachi</text>
   <text y="332.583" x="347.248" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="335.103" x="350.173,352.423,354.673,361.171,363.421,369.919,374.419,378.919,383.419,386.92,390.916,395.416" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.5,0.5,0.39,0.44,0.5,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, A Yokoseki</text>
   <text y="332.583" x="397.918" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="335.103" x="400.842,403.092,405.342,410.841,413.091,418.095,422.091,424.594" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.28,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, E Saji</text>
   <text y="332.583" x="427.095" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="335.103" x="430.02,432.27,434.52,442.521,444.771,451.269,455.769,460.269,464.265,467.262" svgx:width="0.25,0.25,0.89,0.25,0.72,0.5,0.5,0.44,0.33,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, M Hokari</text>
   <text y="332.583" x="469.764" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="335.103" x="472.689,474.939,477.189,483.687,485.937,492.435,496.431,500.931,504.927,509.427,513.423,519.921" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.5,0.44,0.5,0.44,0.72,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Yanagawa</text>
   <text y="332.583" x="523.916" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="335.103" x="526.841,529.091" svgx:width="0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, </text>
   <text y="346.101" x="310.013,318.014,320.264,326.762,329.264,332.765,337.265,339.767,343.763,347.759,354.257" svgx:width="0.89,0.25,0.72,0.28,0.39,0.5,0.28,0.44,0.44,0.72,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M Nishizawa</text>
   <text y="343.583" x="358.255" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="354.581" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="357.103" x="312.941,318.944,321.446,323.948,328.448,332.948,335.45,339.95,342.2,348.698,353.198,355.7,359.696,363.692,367.193,370.694,373.196,375.698,379.694,381.944,384.194,390.692,394.688,399.188,403.688,407.189,409.691,416.189,420.185,424.685,427.187,429.437,433.937,436.439,438.689,444.692,448.688,453.188,456.689,461.189,463.691,468.191,472.691,476.687,478.937,481.187,486.686,490.187,494.687,497.189,501.689,503.939,509.438,513.434,516.935,520.931,525.431,528.932,532.928,537.428" svgx:width="0.67,0.28,0.28,0.5,0.5,0.28,0.5,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.61,0.39,0.5,0.28,0.5,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Niigata University, Department of Neurology, Brain Research </text>
   <text y="368.101" x="310.016,313.013,317.513,321.014,323.516,326.018,328.52,333.02,335.522,339.518,341.768,344.018,350.021,352.523,355.025,359.525,364.025,366.527,371.027,373.277,375.527,379.523,384.023,388.523,393.023" svgx:width="0.33,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.25,0.67,0.28,0.28,0.5,0.5,0.28,0.5,0.25,0.25,0.44,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Institute, Niigata, Japan</text>
   <text y="395.101" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="395.101" x="363.845,369.344,373.844,377.84,380.09,381.323,385.319,389.819,392.321,396.317,399.314,401.816,406.316,409.313,411.563,412.796,417.296,419.798,423.299,427.799,431.795,434.297,436.547,437.78,442.28,446.276,448.778,453.278,459.776,463.772,468.272,470.522,471.755,474.257,477.758,480.008,481.241,485.237,487.487,488.72,491.717,494.714,498.71,503.21,507.71,511.706,516.206,518.708,520.958,522.191,525.692,528.194,530.696,534.692,536.942,538.175,542.675,545.672" svgx:width="0.61,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.44,0.33,0.28,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.39,0.28,0.28,0.44,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The anterior visual pathway is a frequent site of </text>
   <text y="406.099" x="310.016,312.518,317.018,319.52,324.02,327.017,330.932,333.182,335.639,339.635,343.136,345.593,349.094,353.594,358.094,364.592,369.092,371.549,376.049,380.549,383.006,387.506,392.006,394.508,397.01,401.006,403.463,407.963,411.959,416.459,419.456,421.958,424.46,426.962,430.463,432.92,435.917,442.415,448.913,451.91,454.367,458.867,463.367,466.364,468.866,473.366,477.866,480.323,482.825,487.325,491.321,493.778,497.774,502.274,506.774,509.771,513.272,517.268,519.725,524.225,527.222,529.679,534.179,538.175,542.675" svgx:width="0.28,0.5,0.28,0.5,0.33,0.5,0.25,0.25,0.44,0.39,0.25,0.39,0.5,0.5,0.72,0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.28,0.28,0.44,0.25,0.5,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.33,0.72,0.72,0.33,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.5,0.33,0.25,0.5,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">injury, as shown by optic neuritis (ON) during the course of neu-</text>
   <text y="417.097" x="310.016,313.013,317.513,324.515,329.015,333.011,335.513,338.015,340.517,343.019,346.52,348.77,350.282,354.782,359.282,361.784,364.286,368.282,372.278,374.528,376.031,379.028,385.526,393.527,400.025,403.022,405.524,407.774,409.277,413.777,418.277,424.775,428.771,433.271,437.267,439.904,442.154,444.404,445.907,448.409,452.909,456.905,459.155,460.667,465.167,469.163,471.665,475.661,478.163,480.665,484.166,486.416,487.919,492.419,495.416,497.666,499.178,503.678,507.674,510.176,514.676,519.176,526.178,530.174,534.17,538.67,542.666" svgx:width="0.33,0.5,0.78,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.44,0.25,0.55,0.33,0.72,0.89,0.72,0.33,0.28,0.25,0.55,0.5,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">romyelitis optica (NMO); however, the details of pathomecha-</text>
   <text y="428.095" x="310.016,314.516,317.018,320.519,327.521,329.771,332.273,336.773,339.023,345.521,352.019,354.269,358.769,361.766,364.016,370.514,378.515,385.013,387.263,390.26,394.256,401.258,405.254,407.756,412.256,414.506,419.006,423.506,427.502,430.004,434.0,437.996,440.498" svgx:width="0.5,0.28,0.39,0.78,0.25,0.28,0.5,0.25,0.72,0.72,0.25,0.5,0.33,0.25,0.72,0.89,0.72,0.25,0.33,0.44,0.78,0.44,0.28,0.5,0.25,0.5,0.5,0.44,0.28,0.44,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">nism in ON of NMO remain unclear.</text>
   <text y="439.093" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="439.093" x="355.628,360.497,364.997,367.121,371.117,373.619,378.119,382.115,384.617,389.117,393.113,395.615,399.611,401.735,404.237,408.737,412.733,414.857,418.853,421.355,423.857,428.357,430.859,434.855,438.851,441.353,443.477,447.473,451.973,456.473,458.597,461.594,465.59,470.09,472.592,477.092,479.594,484.094,488.594,491.096,495.092,499.088,501.59,503.714,507.71,512.21,516.206,519.203,523.199,527.195,529.697,533.693,536.69,539.192,542.693" svgx:width="0.61,0.5,0.25,0.44,0.28,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.28,0.5,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.33,0.44,0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.44,0.33,0.44,0.44,0.28,0.44,0.33,0.28,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To elucidate the clinical and radiological characteris-</text>
   <text y="450.091" x="310.016,312.518,315.02,319.016,322.517,324.767,329.267,332.264,334.514,338.51,343.01,345.512,349.508,352.505,355.007,359.507,362.504,364.754,369.254,371.756,375.257,379.757,383.753,386.255,388.505,393.005,397.001,399.503,404.003,410.501,414.497,418.997,421.247,423.749,428.249,432.749,437.249,439.751,444.251,448.247,455.249,459.245,463.745,466.247,468.497,470.999,475.499,477.749,484.247,492.248,498.746" svgx:width="0.28,0.28,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.44,0.33,0.28,0.5,0.33,0.25,0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.72,0.89,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tics of anterior visual pathway involvement in NMO.</text>
   <text y="461.089" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="461.089" x="349.112,356.888,360.884,363.485,367.985,371.981,374.978,377.975,382.475,385.472,392.474,396.47,400.97,403.571,407.567,410.168,413.165,417.161,419.663,422.66,427.16,430.661,435.161,439.157,443.153,445.655,448.157,452.657,456.653,459.254,462.755,465.257,469.757,474.257,478.757,481.358,485.858,488.855,491.456,495.956,500.456,503.057,509.555,517.556,524.054,526.655,530.156,534.656,538.652,542.648" svgx:width="0.94,0.44,0.25,0.5,0.44,0.33,0.33,0.5,0.33,0.78,0.44,0.5,0.25,0.44,0.25,0.33,0.44,0.28,0.33,0.5,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.25,0.72,0.89,0.72,0.25,0.39,0.5,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We performed a retrospective study of 17 NMO spec-</text>
   <text y="472.087" x="310.016,312.518,315.515,320.015,327.017,329.591,334.091,336.593,340.094,344.594,347.591,352.091,356.087,359.084,361.658,364.655,371.153,379.154,385.652,389.153,393.653,396.65,399.224,403.724,407.72,410.222,412.724,416.72,421.22,423.722,427.223,429.797,432.794,437.294,441.794,444.368,448.364,450.866,453.368,457.364,461.36,465.86,469.361,472.358,474.932,478.928,483.428,487.928,490.502,495.002,499.502,502.076,510.077,515.081,517.655,522.155,526.151,528.653,531.155,535.151,539.651,542.153,545.654" svgx:width="0.28,0.33,0.5,0.78,0.25,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.25,0.33,0.72,0.89,0.72,0.39,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.25,0.44,0.28,0.28,0.44,0.44,0.5,0.39,0.33,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">trum disorder (NMOsd) patients (28 attacks) and 16 MS patients </text>
   <text y="483.085" x="310.016,313.013,317.513,322.013,324.749,328.745,331.247,333.749,337.745,341.741,346.241,349.742,352.739,355.475,361.973,364.475,366.977,371.477,374.213,378.713,381.215,384.716,387.218,391.718,394.715,399.215,401.951,406.451,409.448,412.184,416.684,419.186,422.687,427.187,431.183,433.685,436.421,438.923,445.925,450.425,454.421,456.923,459.92,466.922,470.918,475.418,477.92,481.421,483.671,486.407,490.403,494.903,499.403,502.139,504.641,509.141,513.641,517.637,521.138,523.64,526.142,530.642,534.638,537.14,541.136,545.636" svgx:width="0.33,0.5,0.5,0.25,0.44,0.28,0.28,0.44,0.44,0.5,0.39,0.33,0.25,0.72,0.28,0.28,0.5,0.25,0.5,0.28,0.39,0.28,0.5,0.33,0.5,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.28,0.78,0.5,0.44,0.28,0.33,0.78,0.44,0.5,0.28,0.39,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(25 attacks) with history of visual impairments, and investigated </text>
   <text y="494.083" x="310.016,314.516,317.018,320.519,325.019,329.015,331.517,334.064,338.06,342.056,346.556,349.058,351.56,356.06,358.607,361.604,366.941,373.439,376.436,378.686,381.233,385.733,388.235,391.736,396.236,400.232,402.734,405.281,408.278,410.78,414.776,417.278,421.778,424.325,427.322,433.82,438.824,441.821,444.071,446.618,451.118,455.618,458.12,460.622,464.618,468.614,471.116,473.663,477.659,482.159,486.659,490.655,493.652,497.648,502.148,506.144,510.14,512.687,515.189,519.689,526.691,531.191,535.691,538.688,542.684" svgx:width="0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.33,0.72,0.72,0.33,0.25,0.25,0.5,0.28,0.39,0.5,0.44,0.28,0.25,0.33,0.28,0.44,0.28,0.5,0.25,0.33,0.72,0.56,0.33,0.25,0.25,0.5,0.5,0.28,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.28,0.5,0.78,0.5,0.5,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">visual acuity (VA), visual field (VF), optical coherence tomogra-</text>
   <text y="505.081" x="310.016,314.516,319.016,323.516,325.514,328.511,335.009,341.012,346.511,349.508,351.758,353.756,357.752,362.252,366.752,368.75,376.751,382.754,385.751,387.749,390.746,393.248,397.748,402.248,404.75,409.25,413.75,417.251,419.501,421.499,424.496,428.996,430.994,433.496,437.996,440.498,443.999,445.997,449.498,452.0,456.5,461.0,464.915,467.165,469.163,472.664,476.66,479.657,484.157,491.159,493.157,495.659,499.655,503.156,505.658,508.16,512.66,517.16,519.158,523.658,526.16,530.156,532.658,537.158,541.154,545.654" svgx:width="0.5,0.5,0.5,0.25,0.33,0.72,0.67,0.61,0.33,0.25,0.25,0.44,0.5,0.5,0.25,0.89,0.67,0.33,0.25,0.33,0.28,0.5,0.5,0.28,0.5,0.5,0.39,0.25,0.25,0.33,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.39,0.44,0.33,0.5,0.78,0.25,0.28,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">phy (OCT), and MRI findings. In this study, serum testing yielded </text>
   <text y="516.079" x="310.016,314.516,319.016,322.517,325.019,327.521,330.023,334.523,338.519,341.039,344.036,348.032,351.533,356.033,358.535,361.037,364.538,367.058,370.055,374.555,377.552,380.072,384.068,388.568,393.068,397.064,401.564,406.064,409.061,411.563,416.063,419.06,423.56,426.08,429.077,435.575,442.073,447.077,451.577,454.574,457.094,461.09,465.59,468.092,470.594,475.094,479.594,484.094,486.596,490.592,494.093,496.613,499.115,503.615,506.135,510.131,512.633,515.135,517.655,522.155,526.151,528.653,531.155,535.151,539.651,542.153,545.654" svgx:width="0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.5,0.44,0.5,0.5,0.33,0.28,0.5,0.33,0.5,0.25,0.33,0.72,0.72,0.56,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">positive results for aquaporin-4 (AQP4) antibodies in all patients </text>
   <text y="527.077" x="310.016,316.514,319.016,321.518,326.018,328.268,334.766,342.767,349.265,352.766,357.266,359.516,361.766,365.762,370.262,374.762,377.012,381.512,385.508,390.008,394.004,396.506,399.008,403.508,407.504,409.754,412.751,416.747,420.248,424.748,427.25,429.752,433.253,435.503,438.005,442.505,444.755,448.751,451.253,453.755,456.005,460.505,464.501,467.003,469.505,473.501,478.001,480.503,484.004,486.254,492.752,495.254,497.756,502.256,504.506,512.507,517.511" svgx:width="0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.39,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.44,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">with NMOsd, and negative results in all patients with MS.</text>
   <text y="538.075" x="310.016,316.514,320.51,324.011,329.015,331.517,334.514,338.015,341.012" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="538.075" x="344.207,349.706,354.206,358.202,360.452,361.397,368.399,372.395,376.391,380.891,383.141,383.924,389.261,395.264,397.514,398.459,402.455,406.955,411.455,413.705,414.65,421.652,425.648,429.644,434.144,436.394,437.339,441.839,445.835,450.335,452.837,456.833,459.335,461.837,466.337,470.837,473.087,474.032,477.029,485.03,491.528,494.525,496.775,497.72,502.22,505.217,507.467,508.25,514.748,519.752,522.002,522.947,526.943,529.445,531.695,532.64,539.138,545.636" svgx:width="0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.89,0.72,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.25,0.55,0.44,0.28,0.25,0.55,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The mean VA and mean deviation (MD) of VF at ON </text>
   <text y="549.073" x="310.016,314.012,316.514,319.016,323.012,327.008,331.508,335.009,337.637,344.135,348.131,351.128,355.124,357.752,361.253,363.755,368.255,372.755,375.257,378.254,380.756,384.752,388.748,393.248,395.75,398.252,402.752,405.38,411.878,416.378,419.375,422.876,426.872,429.509,432.011,436.511,439.139,443.135,447.635,451.631,455.132,457.76,462.26,465.257,467.894,474.392,482.393,488.891,492.392,496.892,499.52,504.02,508.016,510.518,513.02,517.016,521.516,524.018,527.519,530.156,532.658,537.158,541.154,545.654" svgx:width="0.44,0.28,0.28,0.44,0.44,0.5,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.72,0.5,0.33,0.39,0.44,0.25,0.28,0.5,0.25,0.44,0.5,0.44,0.39,0.25,0.5,0.33,0.25,0.72,0.89,0.72,0.39,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">attacks were significantly worse in eyes of NMOsd patients than </text>
   <text y="560.071" x="310.016,312.518,317.018,321.518,325.019,329.015,331.355,335.855,338.852,341.192,349.193,354.197,356.537,361.037,365.033,367.535,370.037,374.033,378.533,381.035,384.536,386.876" svgx:width="0.28,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">those of MS patients (</text>
   <text y="560.071" x="389.873" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="560.071" x="395.372,397.712,402.788,405.128,409.628,411.878,416.378,420.878,425.378,428.375,430.625,432.47,438.968,442.964,446.96,451.46,454.457,458.957,461.459,465.959,470.459,472.799,475.301,479.801,482.141,484.643,489.143,493.139,495.317,501.815,506.819,509.159,513.155,515.657,519.653,523.154,526.655,529.157,532.154,534.656,538.652,542.648" svgx:width="0.25,0.56,0.25,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.25,0.72,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.56,0.25,0.44,0.28,0.44,0.39,0.39,0.28,0.33,0.28,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> &lt; 0.001). According to the VF classifica-</text>
   <text y="571.069" x="310.016,312.518,315.02,319.52,324.02,326.81,331.31,334.811,338.807,343.307,346.097,348.599,353.099,355.889,358.391,362.891,366.887,369.677,376.175,380.675,383.177,385.679,389.675,392.465,398.963,402.959,407.459,410.456,412.958,415.46,417.962,421.463,424.091,429.275,432.272,436.268,440.264,442.766,449.768,453.764,458.264,460.766,463.394,468.578,471.575,474.077,478.073,480.575,482.825,485.615,488.117,492.617,496.613,499.403,502.4,505.397,509.393,513.893,518.393,522.389,526.889,530.885,535.385,538.175,542.675,545.672" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.5,0.28,0.28,0.44,0.25,0.72,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.61,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.61,0.33,0.28,0.44,0.28,0.25,0.25,0.28,0.5,0.44,0.25,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion used in the Optic Neuritis Treatment Trial, the frequency of </text>
   <text y="582.067" x="310.016,316.514,324.515,331.013,334.514,339.014,341.363,345.863,349.859,352.361,354.863,358.859,363.359,365.861,369.362,371.711,378.209,380.711,383.213,387.713,390.062,392.564,397.064,399.566,403.562,406.064,408.413,410.915,415.415,418.916,422.417,424.766,429.266,432.263,434.612,439.112,441.614,445.115,447.617,452.117,456.617,458.966,465.464,469.46,472.961,475.31,478.811,481.313,485.813,490.313,492.815,495.812,498.314,502.31,506.306,510.806,513.308,515.81,520.31,522.659,527.159,529.661,534.161,538.661,542.657,545.654" svgx:width="0.72,0.89,0.72,0.39,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.28,0.44,0.28,0.25,0.28,0.5,0.39,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMOsd patients with total loss of vision was significantly higher </text>
   <text y="593.065" x="310.016,312.518,317.018,321.014,325.514,327.764,328.871,331.373,335.873,339.869,342.371,344.621,345.728,350.228,353.225,355.475,356.582,364.583,369.587,371.837,372.944,377.444,381.44,383.942,386.444,390.44,394.94,397.442,400.943,403.193,404.3,408.296,410.798,413.048,414.155,420.653,427.151,429.401,430.508,434.504,437.006,439.508,443.504,447.5,452.0,455.501,457.751,458.858" svgx:width="0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.28,0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.28,0.28,0.44,0.44,0.5,0.39,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">than that of MS patients at ON attacks (</text>
   <text y="593.065" x="461.855" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="593.065" x="467.354,469.604,470.711,475.787,478.037,479.144,483.644,485.894,490.394,494.894,497.891,500.141,502.391,503.498,507.998,512.498,515.0,517.25,518.357,520.859,525.359,529.355,531.605,532.712,535.709,538.706,542.702" svgx:width="0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> &lt; 0.01), but the fre-</text>
   <text y="604.063" x="310.016,314.516,319.016,323.012,327.512,331.508,336.008,337.97,342.47,345.467,347.429,353.927,361.928,368.426,371.927,376.427,378.389,382.889,386.885,389.387,391.889,395.885,400.385,402.887,406.388,408.35,414.848,417.35,419.852,424.352,426.314,430.31,434.306,438.806,441.308,444.305,448.301,450.803,452.765,456.761,461.261,465.761,470.261,473.258,480.26,484.256,486.758,489.26,491.762,494.264,498.26,501.761,503.723,510.221,514.217,517.718,519.68,523.181,525.683,530.183,534.683,537.185,540.182,542.684" svgx:width="0.5,0.5,0.44,0.5,0.44,0.5,0.25,0.5,0.33,0.25,0.72,0.89,0.72,0.39,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.44,0.5,0.28,0.33,0.44,0.28,0.25,0.44,0.5,0.5,0.5,0.33,0.78,0.44,0.28,0.28,0.28,0.28,0.44,0.39,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">quency of NMOsd patients with central abnormalities was signifi-</text>
   <text y="615.061" x="310.016,314.012,318.008,322.508,325.01,327.512,332.012,334.262,337.889,340.391,344.891,351.389,355.385,358.382,360.632,364.259,366.761,371.261,375.257,379.757,382.007,385.634,388.136,392.636,396.632,399.134,401.384,405.011,409.511,412.508,414.758,418.385,426.386,431.39,433.64,437.267,441.263,443.765,446.015,449.642,456.14,462.638,464.888,468.515,472.511,475.013,477.515,481.511,485.507,490.007,493.508,495.758,499.385" svgx:width="0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.72,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.44,0.28,0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.28,0.28,0.44,0.44,0.5,0.39,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cantly lower than that of MS at ON attacks (</text>
   <text y="615.061" x="502.382" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="615.061" x="507.881,510.131,513.758,518.834,521.084,524.711,529.211,531.461,535.961,540.461,543.458,545.708" svgx:width="0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> &lt; 0.05). </text>
   <text y="626.059" x="310.016,316.019,320.519,325.019,327.521,330.518,334.514,338.015,340.517,343.514,347.51,352.01,356.51,360.506,365.006,369.002,372.998,377.498,379.883,387.884,393.887,396.884,399.269,403.265,406.766,410.267,414.263,417.764,421.265,428.267,432.263,436.763,439.265,442.766,445.151,449.147,451.649,454.034,460.532,467.03,469.415,473.411,475.913,478.415,482.411,486.407,490.907,494.408,496.793,499.295,503.795,508.295,510.797,514.793,518.789,521.291,525.287,529.787,532.172,534.674,539.174,543.17,545.672" svgx:width="0.67,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.33,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25,0.89,0.67,0.33,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.39,0.25,0.44,0.28,0.25,0.72,0.72,0.25,0.44,0.28,0.28,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Contrast-enhanced MRI assessments at ON attacks indicated that </text>
   <text y="637.057" x="310.016,312.518,317.018,321.014,322.643,325.145,329.141,333.641,338.141,340.643,345.143,346.772,351.272,354.269,355.898,359.894,364.394,368.894,373.394,376.391,383.393,387.389,389.891,392.393,396.893,398.522,402.518,407.018,411.518,415.514,420.014,424.01,428.006,432.506,434.135,436.637,440.633,444.134,446.636,451.136,455.636,459.137,460.766,463.268,467.768,469.397,473.897,477.893,480.395,482.897,486.893,491.393,493.895,497.396,499.025,505.523,508.025,510.527,515.027,516.656,523.154,531.155,537.653,541.154,545.654" svgx:width="0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.5,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.25,0.28,0.44,0.39,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.89,0.72,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">the length of abnormally enhanced lesions in patients with NMOsd </text>
   <text y="648.055" x="310.016,316.514,320.51,324.011,326.378,329.879,332.381,336.881,341.381,343.883,346.88,349.382,353.378,357.374,361.874,364.376,366.878,371.378,373.745,376.247,380.747,385.247,389.747,393.743,396.74,399.107,401.609,406.109,410.105,414.605,416.972,419.474,423.974,427.97,430.472,432.839,435.341,439.841,442.217,446.717,450.713,453.215,455.717,459.713,464.213,466.715,470.216,472.583,479.081,481.583,484.085,488.585,490.952,498.953,503.957,506.324" svgx:width="0.72,0.44,0.39,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.28,0.5,0.5,0.5,0.44,0.33,0.25,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.89,0.56,0.25,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was significantly longer than that in patients with MS (</text>
   <text y="648.055" x="509.321" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="648.055" x="514.82,517.187,522.263,524.639,529.139,531.389,535.889,540.389,543.386,545.636" svgx:width="0.25,0.56,0.25,0.5,0.25,0.5,0.5,0.33,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> &lt; 0.05). </text>
   <text y="659.053" x="310.016,318.017,322.517,325.514,329.51,334.01,338.51,342.506,345.143,347.393,349.643,351.173,355.673,360.173,362.675,365.177,369.173,371.423,372.953,377.453,381.449,384.446,386.948,391.448,395.444,399.944,402.941,405.443,407.945,410.447,413.948,416.198,418.448,419.978,422.975,426.971,429.968,433.964,436.961,439.958,443.954,448.454,450.704,452.234,454.736,459.236,461.486,463.016,467.012,470.513,472.763,474.293,477.29,479.792,482.789,486.785,493.787,496.289,499.286,503.282,507.278,511.778,514.028,515.558,519.059,521.561,526.061,530.561,532.892,535.142,536.672,541.172,545.672" svgx:width="0.89,0.5,0.33,0.44,0.5,0.5,0.44,0.33,0.25,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.55,0.33,0.44,0.33,0.44,0.33,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.33,0.28,0.33,0.44,0.78,0.28,0.33,0.44,0.44,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Moreover, optic perineuritis, referred to as ‘tramtrack sign’ on </text>
   <text y="670.051" x="310.016,314.012,318.512,321.014,325.01,327.512,329.762,330.725,335.225,337.727,341.723,348.221,351.722,353.972,354.935,359.435,362.432,364.682,365.645,373.646,379.649,382.646,384.896,385.859,389.855,394.355,398.855,401.105,402.068,405.065,409.565,414.065,418.565,423.065,427.565,432.065,436.565,439.067,441.317,442.28,445.781,448.283,452.783,457.283,459.614,461.864,462.827,467.327,471.827,474.077,475.04,479.036,483.536,486.533,491.033,495.533,499.529,502.031,504.281,505.244,509.744,512.246,516.242,522.74,526.241,528.491,530.741,531.704,538.202,542.198,545.699" svgx:width="0.44,0.5,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.44,0.72,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.89,0.67,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.5,0.33,0.5,0.5,0.44,0.28,0.25,0.55,0.5,0.28,0.44,0.72,0.39,0.25,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">axial views of MRI and ‘doughnut sign’ on coronal views, was </text>
   <text y="681.049" x="310.016,314.516,317.513,321.509,325.01,329.006,333.506,336.008,338.87,341.372,345.872,348.743,353.243,357.743,360.245,363.107,367.607,372.107,374.609,379.109,381.971,389.972,394.976,397.838,402.338,406.334,408.836,411.338,415.334,419.834,422.336,425.837,428.699,431.696,436.196,440.696,448.193,451.19,454.052,458.552,463.052,465.554,468.416,472.412,474.914,478.415,482.915,485.777,492.275,500.276,506.774,510.275,514.775,517.637,522.137,526.133,528.635,531.137,535.133,539.633,542.135,545.636" svgx:width="0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.5,0.5,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.83,0.33,0.25,0.5,0.5,0.28,0.25,0.44,0.28,0.39,0.5,0.25,0.72,0.89,0.72,0.39,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">present in not only MS patients (29%) but also NMOsd patients </text>
   <text y="692.047" x="310.016,313.013,317.513,322.013,329.51,332.507,334.757,337.007,337.781,341.282,345.782,350.282,354.782,358.778,362.279,364.781,367.283,371.783,376.283,378.533,379.307,383.303,387.803,390.305,394.805,398.801,403.301,407.297,411.293,413.543,414.317,418.817,421.814,424.064,424.838,429.338,433.838,436.34,438.842,442.838,445.088,445.862,450.362,454.358,457.355,461.855,465.851,468.101,468.875,472.376,476.876,480.872,484.868,487.37,491.87,494.12,494.894,497.396,501.896,504.893,507.395,511.391,518.393,525.395,529.391,531.893,534.395,538.895,543.395,545.645" svgx:width="0.33,0.5,0.5,0.83,0.33,0.25,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.44,0.33,0.5,0.44,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(46%), suggesting evidence of optic nerve sheath inflammation. </text>
   <text y="703.045" x="310.016,316.514,322.517,327.854,330.464,334.46,337.961,341.462,345.458,348.959,352.46,359.462,363.458,367.958,370.46,373.07,375.572,380.072,382.682,389.18,397.181,403.679,407.18,411.68,414.29,418.79,422.786,429.788,434.288,438.788,442.289,444.791,447.788,451.784,454.286,458.282,462.782,465.392,469.388,471.998,474.5,479.0,481.502,486.002,490.502,494.498,497.495,500.105,503.102,507.098,509.6,512.102,516.602,520.598,523.1,525.71,530.21,534.206,537.203,541.703,545.699" svgx:width="0.72,0.67,0.61,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.72,0.89,0.72,0.39,0.5,0.25,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.44,0.25,0.28,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.33,0.44,0.28,0.28,0.5,0.44,0.28,0.25,0.5,0.44,0.33,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">OCT assessment in NMOsd demonstrated a thinner retinal nerve </text>
   <text y="714.043" x="310.016,313.013,315.515,320.015,324.011,327.008,329.258,330.779,333.281,337.277,341.777,345.773,348.77,351.02,352.541,355.043,359.543,363.539,368.039,370.289,371.81,374.312,378.812,381.062,382.583,390.584,395.588,397.838,399.359" svgx:width="0.33,0.28,0.5,0.44,0.33,0.25,0.55,0.28,0.44,0.5,0.44,0.33,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fiber layer than in MS (</text>
   <text y="714.043" x="402.356" svgx:width="0.61" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">P</text>
   <text y="714.043" x="407.855,410.105,411.626,416.702,418.952,420.473,424.973,427.223,431.723,436.223,439.22,441.47,443.72,445.241,448.238,455.24,459.74,464.24,467.237,469.739,473.735,478.235,480.737,483.239,487.154,489.404,491.654,493.175,499.673,506.171,508.421,509.942,513.938,518.438,522.434,525.935,528.185,529.706,536.204,538.706,541.208,545.708" svgx:width="0.25,0.55,0.56,0.25,0.55,0.5,0.25,0.5,0.5,0.33,0.25,0.25,0.55,0.33,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.28,0.5,0.25,0.25,0.55,0.72,0.72,0.25,0.55,0.44,0.5,0.44,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> &lt; 0.05). Importantly, ON eyes with </text>
   <text y="725.041" x="310.016,316.514,324.515,331.013,334.514,339.014,341.264,343.253,347.753,351.749,354.251,356.753,360.749,365.249,367.751,371.252,373.502,375.491,379.991,383.987,388.487,390.737,392.726,399.728,404.228,407.225,411.221,413.471,415.46,419.96,422.957,427.457,429.959,434.459,438.959,443.459,447.455,451.955,454.205,456.194,458.696,461.198,468.2,472.196,474.446,476.435,479.432,482.429,486.929,493.931,496.181,498.17,504.668,511.166,513.4159999999999,515.405,519.905,524.405,527.906,531.902,534.404,536.654,538.643,541.145,545.645" svgx:width="0.72,0.89,0.72,0.39,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.5,0.25,0.55,0.78,0.5,0.33,0.44,0.25,0.55,0.5,0.33,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.28,0.78,0.44,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.72,0.72,0.25,0.55,0.5,0.5,0.39,0.44,0.28,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">NMOsd patients had more prolonged time from ON onset to </text>
  </g>
 </g>
</svg>
